GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ironwood Pharmaceuticals Inc (STU:I76) » Definitions » Cyclically Adjusted PB Ratio

Ironwood Pharmaceuticals (STU:I76) Cyclically Adjusted PB Ratio : 10.36 (As of Jun. 07, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Ironwood Pharmaceuticals Cyclically Adjusted PB Ratio?

As of today (2024-06-07), Ironwood Pharmaceuticals's current share price is €5.80. Ironwood Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €0.56. Ironwood Pharmaceuticals's Cyclically Adjusted PB Ratio for today is 10.36.

The historical rank and industry rank for Ironwood Pharmaceuticals's Cyclically Adjusted PB Ratio or its related term are showing as below:

STU:I76' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 9.6   Med: 19   Max: 31.95
Current: 10.31

During the past years, Ironwood Pharmaceuticals's highest Cyclically Adjusted PB Ratio was 31.95. The lowest was 9.60. And the median was 19.00.

STU:I76's Cyclically Adjusted PB Ratio is ranked worse than
93.22% of 737 companies
in the Drug Manufacturers industry
Industry Median: 1.88 vs STU:I76: 10.31

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Ironwood Pharmaceuticals's adjusted book value per share data for the three months ended in Mar. 2024 was €-1.913. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €0.56 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Ironwood Pharmaceuticals Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Ironwood Pharmaceuticals's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ironwood Pharmaceuticals Cyclically Adjusted PB Ratio Chart

Ironwood Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.29 26.68 19.91 15.24 16.24

Ironwood Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.40 12.67 12.46 16.24 14.05

Competitive Comparison of Ironwood Pharmaceuticals's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Ironwood Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ironwood Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ironwood Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Ironwood Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.



Ironwood Pharmaceuticals Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Ironwood Pharmaceuticals's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=5.80/0.56
=10.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ironwood Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Ironwood Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-1.913/131.7762*131.7762
=-1.913

Current CPI (Mar. 2024) = 131.7762.

Ironwood Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.750 100.560 0.983
201409 0.601 100.428 0.789
201412 0.510 99.070 0.678
201503 0.443 99.621 0.586
201506 0.877 100.684 1.148
201509 0.627 100.392 0.823
201512 0.610 99.792 0.806
201603 0.565 100.470 0.741
201606 0.499 101.688 0.647
201609 0.364 101.861 0.471
201612 0.430 101.863 0.556
201703 0.187 102.862 0.240
201706 0.029 103.349 0.037
201709 -0.099 104.136 -0.125
201712 0.055 104.011 0.070
201803 -0.097 105.290 -0.121
201806 -0.246 106.317 -0.305
201809 -1.099 106.507 -1.360
201812 -1.118 105.998 -1.390
201903 -1.349 107.251 -1.657
201906 -1.241 108.070 -1.513
201909 -0.886 108.329 -1.078
201912 -0.533 108.420 -0.648
202003 -0.406 108.902 -0.491
202006 -0.205 108.767 -0.248
202009 0.031 109.815 0.037
202012 0.321 109.897 0.385
202103 0.572 111.754 0.674
202106 2.609 114.631 2.999
202109 3.017 115.734 3.435
202112 3.309 117.630 3.707
202203 3.031 121.301 3.293
202206 3.291 125.017 3.469
202209 3.894 125.227 4.098
202212 3.998 125.222 4.207
202303 4.250 127.348 4.398
202306 -2.045 128.729 -2.093
202309 -1.940 129.860 -1.969
202312 -2.031 129.419 -2.068
202403 -1.913 131.776 -1.913

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Ironwood Pharmaceuticals  (STU:I76) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Ironwood Pharmaceuticals Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Ironwood Pharmaceuticals's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Ironwood Pharmaceuticals (STU:I76) Business Description

Traded in Other Exchanges
Address
100 Summer Street, Suite 2300, Boston, MA, USA, 02110
Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Ironwood Pharmaceuticals (STU:I76) Headlines

No Headlines